IPO registrations (S-1, F-1) · Registrants

Zynerba Pharmaceuticals, Inc.

SEC CIK
1621443 · filings on EDGAR ↗
Former names
Zynerba Pharmeceuticals, Inc. (2014–2015)
Registration
Form S-1, first filed 2015-06-30, last 2015-07-31; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2015-08-05; declared effective 2015-08-04
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
80 W. LANCASTER AVENUE, SUITE 300, Devon, PA 19333
EIN
26-0389433
EDGAR entity type
operating
Insiders and CEO pay
Zynerba Pharmaceuticals, Inc. on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2015-07-31)
Final price
$14.00 per share, within the range (424B4 filed 2015-08-05, an initial public offering)
Shares sold
3,000,000
Gross proceeds
$42,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ZYNE
Lead underwriters
Jefferies; Piper Sandler
Syndicate
Canaccord Genuity; Oppenheimer

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2015-06-30S-1S-1 (registration)Zynerba Pharmeceuticals, Inc.0001047469-15-005872 ↗
2015-07-23S-1/AS-1/A (amendment)Zynerba Pharmaceuticals, Inc.0001047469-15-006272 ↗
2015-07-31S-1/AS-1/A (amendment)Zynerba Pharmaceuticals, Inc.0001047469-15-006467 ↗
2015-08-04EFFECTEFFECT (declared effective)Zynerba Pharmaceuticals, Inc.9999999995-15-002172 ↗
2015-08-05424B4424B4 (final prospectus)Zynerba Pharmaceuticals, Inc.0001047469-15-006601 ↗
2016-09-12EFFECTEFFECT (declared effective)Zynerba Pharmaceuticals, Inc.9999999995-16-005674 ↗
2017-06-15EFFECTEFFECT (declared effective)Zynerba Pharmaceuticals, Inc.9999999995-17-001537 ↗
2017-06-22EFFECTEFFECT (declared effective)Zynerba Pharmaceuticals, Inc.9999999995-17-001633 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-07-31S-1/Aregistration statement$13.00–$15.003,000,000-Nasdaq ZYNE4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2015-08-05424B4final prospectus$14.003,000,000$42,000,000Nasdaq ZYNE4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ANIDO ARMANDODirector,OfficerChairman & CEO; Chairman & Chief Exec Officer; Chairman & Chief Exec. Officer182015–2023
BARON RICHARD AOfficerChief Financial Officer32015
COOPER WARREN DDirector112015–2023
FEDERICI WILLIAM JDirector182015–2023person page Fuzzy
Hanlon Suzanne M.OfficerGeneral Counsel; Sec, General Counsel & VP HR; Sec, VP & General Counsel92015–2021
HARRISON THOMAS LDirector92015–2018
KISNER DANIEL LDirector112015–2023
MOCH KENNETH IDirector222015–2023
RAPP MICHAELTenPercentOwner92015–2018
Rask Cynthia AnnDirector62015–2017
Sebree Terri BOfficerPresident152015–2023
Fickenscher James EOfficerChief Financial Officer172016–2023
Rosenberger BrianOfficerVP, Commercial; VP, Commercial & Business Dev.132017–2023
Butler John P.Director102018–2023
Stephenson PamelaDirector82019–2023
Parker Albert POfficerChief Legal Officer72022–2023
Jones Kenneth TOfficerSee Remarks32023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2014-10-09Zynerba Pharmeceuticals, Inc.Pharmaceuticals$13,000,000$7,309,180301

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorZYNERBA PHARMACEUTICLAS, INC.PAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerZynerba Pharmeceuticals, Inc.PAForm D private offeringsCIK (EXACT)
Lobbying clientZYNERBA PHARMACEUTICALSPAFederal lobbying (LDA)name and state
Lobbying clientZYNERBA PHARMACEUTICALS, INC.PAFederal lobbying (LDA)name and state
Lobbying clientZYNERBA PHARMACEUTICALS, INC.PAFederal lobbying (LDA)name and state
Patent assigneeZYNERBA PHARMACEUTICALS, INC.PAPatents (USPTO)name and state
SEC filerZynerba Pharmaceuticals, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerZynerba Pharmaceuticals, Inc.PATrademarks (USPTO)name and state
Form 5500 plan sponsorZYNERBA PHARMACEUTICLAS, INC.EIN (EXACT)
Person pageWilliam J FedericiPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, PA first:

More with this interest.

In other datasets, the same topic (Health) in PA:

Interests: Pharmaceutical Preparations · Health